Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
And pioneers like yourself showed that if you gave people a structured program of diet and physical activity, and most importantly, if you gave them behavioral strategies to improve their treatment adherence, then 80% of people would stay in treatment for 16 to 26 weeks
Stopping points If side effects do not resolve with slower injection or dose reduction, the most common research-planning response is to pause, reassess, and consult a clinician before resuming
J., King L
When to contact your GP : Discuss GLP-1 treatment if you have type 2 diabetes with suboptimal control despite lifestyle changes and other medications, or if you're struggling with obesity-related health complications despite sustained efforts at dietary modification and increased physical activity
GLP-1 Receptor Agonist Market Insights, By Drug Class: Liraglutide Contributes the Highest Share of the Market Owing to its Effectiveness and Superior Efficacy In terms of drug type, liraglutide is expected to contribute 26.5% share of the market in 2026, as its once-daily subcutaneous administration provides consistent glycemic control throughout the day
US$ 22.55
US$ 24.64
US$ 21.39
US$ 26.72
